IL40785A - Pharmaceutical compositions comprising 2-p-chlorophenoxy-2-methyl-propionic acid and tocopherol - Google Patents

Pharmaceutical compositions comprising 2-p-chlorophenoxy-2-methyl-propionic acid and tocopherol

Info

Publication number
IL40785A
IL40785A IL40785A IL4078572A IL40785A IL 40785 A IL40785 A IL 40785A IL 40785 A IL40785 A IL 40785A IL 4078572 A IL4078572 A IL 4078572A IL 40785 A IL40785 A IL 40785A
Authority
IL
Israel
Prior art keywords
composition
tocopherol
chlorophenoxy
ester
pharmaceutically acceptable
Prior art date
Application number
IL40785A
Other versions
IL40785A0 (en
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of IL40785A0 publication Critical patent/IL40785A0/en
Publication of IL40785A publication Critical patent/IL40785A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1382587 Blood cholesterol-lowering medicines IMPERIAL CHEMICAL INDUSTRIES Ltd 30 Oct 1972 [16 Dec 1971] 58398/71 Heading A5B Pharmaceutical compositions having hypocholesterolemic and serum triglyceride-lowering action comprise 2-p-chlorophenoxy-2- methylpropionic acid or an ester, amide or salt thereof and from 10 to 25% by weight thereof of a tocopherol having vitamin A activity, e.g. α-, #-, γ- or #-tocopherol, esters thereof and mixtures. Suitable esters of the propionic acid derivatives include those with alcohols R'OH where R' is piperidyl or alkyl substituted by pyridyl or nicotinoyloxy groups. The compositions may be in conventional orally administrable forms comprising the axial excipients and carriers. [GB1382587A]

Claims (9)

40785/3 WHAT WE CLAIM IS:
1. A pharmaceutical composition comprising 2-p-chloro-phenoxy-2-methylpropionic acid, the ethyl or 1 , 3-trimethylene di-ester thereof or the sodium, potassium or calcium salt or the aluminium hydroxide di-salt thereof, and from 10% to 25% of the weight thereof of a tocopherol possessing vitamin E activity or an ester thereof, in pharmaceutically acceptable form.
2. A composition as claimed in claim 1 wherein the pharmaceutically acceptable form is a mixture together with a pharmaceutically acceptable diluent.
3. A composition as claimed in claim 2 which is in the form of a tablet, capsule, suspension, emulsion, dispersible powder, syrup or elixir.
4. A composition as claimed in claim 1 wherein the pharmaceutically acceptable form is a dosage unit in which the active ingredients are enclosed without any additional diluent.
5. A composition as claimed in claim 4 which is in the form of a capsule.
6. A composition as claimed in any preceding claim y- or J"-tocopherol or a mixture thereof, and the ester of a tocopherol is an ester with acetic acid or succinic acid.
7. A composition as claimed in claim 6 comprising active ingredients ethyl 2-p-chlorophenoxy-2-methylpropionate and DL- -tocopheryl acetate. 40785/3"
8. A composition as claimed in claim 7 which is in the form of a gelatin capsule containing 425 mg. of ethyl 2-p-chlorophenoxy-2-methylpropionate and 75-80 mg. of DL-to^-tocopheryl acetate.
9. A composition as claimed in claim 1 substantially as described in Example 1. S.HOROWITZ S CD. AGENTS FOR APPLICANTS
IL40785A 1971-12-16 1972-11-09 Pharmaceutical compositions comprising 2-p-chlorophenoxy-2-methyl-propionic acid and tocopherol IL40785A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5839871A GB1382587A (en) 1971-12-16 1971-12-16 Pharmaceutical compositions comprising 2-rho-chlorophenoxy-2- methylpropionic acid or a derivative and a tocopherol possessing vitamin e activity

Publications (2)

Publication Number Publication Date
IL40785A0 IL40785A0 (en) 1973-02-28
IL40785A true IL40785A (en) 1976-02-29

Family

ID=10481514

Family Applications (1)

Application Number Title Priority Date Filing Date
IL40785A IL40785A (en) 1971-12-16 1972-11-09 Pharmaceutical compositions comprising 2-p-chlorophenoxy-2-methyl-propionic acid and tocopherol

Country Status (11)

Country Link
JP (1) JPS4867420A (en)
AU (1) AU470387B2 (en)
BE (1) BE792855A (en)
CA (1) CA981579A (en)
DE (1) DE2261504A1 (en)
FR (1) FR2163736B1 (en)
GB (1) GB1382587A (en)
IE (1) IE36820B1 (en)
IL (1) IL40785A (en)
NL (1) NL7216837A (en)
ZA (1) ZA727855B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2730231B1 (en) * 1995-02-02 1997-04-04 Fournier Sca Lab COMBINATION OF FENOFIBRATE AND VITAMIN E, USE IN THERAPEUTICS

Also Published As

Publication number Publication date
GB1382587A (en) 1975-02-05
IE36820B1 (en) 1977-03-02
AU4873672A (en) 1974-05-16
NL7216837A (en) 1973-06-19
FR2163736A1 (en) 1973-07-27
JPS4867420A (en) 1973-09-14
ZA727855B (en) 1973-08-29
BE792855A (en) 1973-06-15
AU470387B2 (en) 1976-03-11
DE2261504A1 (en) 1973-06-28
CA981579A (en) 1976-01-13
FR2163736B1 (en) 1976-03-05
IE36820L (en) 1973-06-16
IL40785A0 (en) 1973-02-28

Similar Documents

Publication Publication Date Title
JP2003526595A5 (en)
GB1389814A (en) Cysteine derivatives and production thereof
EP0295637B1 (en) Lipid regulating compositions
US4234601A (en) Analgesic potentiation
US4233316A (en) Analgesic potentiation
US4233314A (en) Analgesic potentiation
AP460A (en) Naphthyl derivative for treatment method.
US3144387A (en) Anti-inflammatory compositions
IL40785A (en) Pharmaceutical compositions comprising 2-p-chlorophenoxy-2-methyl-propionic acid and tocopherol
PT85871B (en) Process for the preparation of orally administrable pharmaceutical compositions which contain chenodeoxycholic acid or deoxycholic acid or a salt of either of these acids any of wich may be used alone or is combination with a synergist
US3917832A (en) Compositions comprising d-thyroxine and d-triiodothyronine
US4590183A (en) Gastric cytoprotection with sodium thiosulfate in oral administration of aspirin
GB1411701A (en) Compositions containing compounds of the eburnane structure
GB1456324A (en) Cycloalkyl phenoxy carboxylic acid derivatives processes for producing them and compositions containing them
US2910403A (en) Anti hypertensive compositions comprising 2-methyl-5, 8-dimethoxychromone and acetamides
GB955627A (en) Therapeutic composition comprising antibiotics
US4585764A (en) Gastric cytoprotection with 3,3'-thiobis[propanoic acid] in oral administration of aspirin
US3013942A (en) Therapeutic erythromycin ester compositions
KR840006810A (en) Process for preparing cephalosporin ester
IE34275B1 (en) Alpha-hydrazino acids
US3703580A (en) Antibacterial medicinal compositions
GB890638A (en) Compositions for combating retinitis pigmentosa
GB1280244A (en) Serum triglyceride-lowering compositions
JPH09169642A (en) Tetrahydrozolilne-containing solution
JPS6123796B2 (en)